Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
LFST
BUYLifeStance Health Group, Inc. · Healthcare · United States · $4.2B · Avg Vol: $41M/d
COMPANY DESCRIPTION
LifeStance Health Group, Inc. is one of the largest U.S. providers of outpatient mental health services, offering a comprehensive range of psychiatric and therapy services across multiple states. The company addresses the growing demand for accessible mental healthcare through a network of employed and affiliated clinicians, leveraging technology for both in-person and telehealth appointments. Its scale and integrated care model position it as a significant player in the rapidly expanding behavioral health market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 859.5M | 1.1B | 1.3B | 1.4B | 18.3% | 1.5B | 1.7B | 1.9B | 15.5% |
| EPS | -0.61 | -0.51 | -0.15 | 0.03 | — | 0.06 | 0.05 | — | 70.8% |
| Shares | 376.0M | 378.7M | 382.7M | 388.3M | +3.3% | 381.8M | — | — | — |
| Debt | 476.5M | 511.0M | 485.2M | 474.5M | -0.1% | 476.8M | — | — | — |
| Equity | 1.5B | 1.4B | 1.4B | 1.5B | 0.1% | — | — | — | — |
| Op CF | 52.8M | -16.9M | 107.3M | 146.2M | 40.4% | 182.4M | — | — | — |
| Inv CF | -139.5M | -60.3M | -21.6M | -36.1M | — | — | — | — | — |
| Fin CF | 47.3M | 47.4M | -9.9M | -16.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LFST are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| LFST | LifeStance Health Group, Inc.(you) | $4.2B | 77 | BUY |
| CON | Concentra Group Holdings Parent, Inc. | $4.0B | 83 | STRONG BUY |
| ACHC | Acadia Healthcare Company, Inc. | $3.2B | 73 | BUY |
| PACS | PACS Group, Inc. | $7.4B | 78 | BUY |
| NHC | National HealthCare Corporation | $3.5B | 90 | STRONG BUY |
| INNV | InnovAge Holding Corp. | $1.6B | 77 | BUY |
| OPCH | Option Care Health, Inc. | $3.4B | 61 | HOLD |
| CHE | Chemed Corporation | $6.8B | 88 | STRONG BUY |
| ASTH | Astrana Health, Inc. | $2.0B | 85 | STRONG BUY |
| SGRY | Surgery Partners, Inc. | $2.1B | 68 | BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.6%